0001493152-21-030335.txt : 20211202
0001493152-21-030335.hdr.sgml : 20211202
20211202182758
ACCESSION NUMBER: 0001493152-21-030335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211130
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERMAN ROBERT ANDREW
CENTRAL INDEX KEY: 0001258360
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38325
FILM NUMBER: 211468107
MAIL ADDRESS:
STREET 1: C/O ITUS CORPORATION
STREET 2: 12100 WILSHIRE BOULEVARD, SUITE 1275
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: enVVeno Medical Corp
CENTRAL INDEX KEY: 0001661053
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330936180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-261-2900
MAIL ADDRESS:
STREET 1: 70 DOPPLER
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Hancock Jaffe Laboratories, Inc.
DATE OF NAME CHANGE: 20151215
4
1
ownership.xml
X0306
4
2021-11-30
0
0001661053
enVVeno Medical Corp
NVNO
0001258360
BERMAN ROBERT ANDREW
C/O JAFFE LABORATORIES,
70 DOPPLER
IRVINE
CA
92618
1
1
0
0
Chief Executive Officer
Common Stock
2021-11-30
4
A
0
200000
A
207736
D
Stock Options
6.70
2021-11-30
4
A
0
349781
0
A
2031-11-30
Common Stock
349781
349781
D
The Reporting Person was granted 200,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve.
The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024.
/s/ Robert A. Berman
2021-12-02